Who owns CARISMA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Carisma Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Carisma Therapeutics stock

Who bought or sold CARISMA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BlackRock 1.7M $3.9M -1% Mar 2024
 View chart
Vanguard Group 1.6M $3.6M 1% Mar 2024
 View chart
Tpg Gp A 1.5M $3.3M -14% Mar 2024
 View chart
Trustees Of The University Of Pennsylvania 1.3M $2.8M -29% Mar 2024
 View chart
Geode Capital Management 529k $1.2M 5% Mar 2024
 View chart
Northern Trust 221k $501k 12% Mar 2024
 View chart
Bridgeway Capital Management 215k $488k 5% Mar 2024
 View chart
Nuveen Asset Management 103k $233k 3% Mar 2024
 View chart
Bank of New York Mellon 78k $176k -7% Mar 2024
 View chart
Charles Schwab Investment Management 61k $138k -16% Mar 2024
 View chart
Morgan Stanley 41k $94k 53% Mar 2024
 View chart
Arrowstreet Capital, Limited Partnership 41k $92k -12% Mar 2024
 View chart
Two Sigma Investments 41k $92k 60% Mar 2024
 View chart
Citadel Advisors 39k $89k 100% Mar 2024
 View chart
Rhumbline Advisers 35k $80k 2% Mar 2024
 View chart
UBS Group 27k $62k -8% Mar 2024
 View chart
Empowered Funds 27k $61k -39% Mar 2024
 View chart
Blodgett Wealth Advisors 26k $58k 0% Mar 2024
 View chart
FMR 24k $55k -16% Mar 2024
 View chart
Bank of America Corporation 22k $49k -51% Mar 2024
 View chart
Wells Fargo & Company 19k $44k 137% Mar 2024
 View chart
Barclays 19k $42k -49% Mar 2024
 View chart
CIBC Global Asset Management 15k $34k 0% Mar 2024
 View chart
American International 13k $39k 0% Dec 2023
 View chart
Connor, Clark & Lunn Investment Management 13k $30k 100% Mar 2024
 View chart
Stratos Wealth Partners 13k $29k 100% Mar 2024
 View chart
XTX Topco 13k $29k 100% Mar 2024
 View chart
Deutsche Bank Aktiengesellschaft 12k $28k 0% Mar 2024
 View chart
Jpmorgan Chase & Co 12k $27k -34% Mar 2024
 View chart
Tower Research Capital 10k $23k -6% Mar 2024
 View chart
Occudo Quantitative Strategies 10k $23k 100% Mar 2024
 View chart
Citigroup 5.0k $11k 31% Mar 2024
 View chart
California State Teachers Retirement System 2.7k $6.1k -54% Mar 2024
 View chart
New York State Common Retirement Fund 2.4k $5.0k 0% Mar 2024
 View chart
Summit Investment Advisors 2.2k $5.0k 0% Mar 2024
 View chart
Legal & General Group 2.2k $4.9k 0% Mar 2024
 View chart
Group One Trading 1.2k $2.8k -86% Mar 2024
 View chart
Royal Bank of Canada 1.0k $2.4k -88% Mar 2024
 View chart
Amalgamated Bank 899.00 $2.0k -61% Mar 2024
 View chart
Peoples Bank 250.00 $565.000000 0% Mar 2024
 View chart
IFP Advisors 206.00 $603.003200 0% Dec 2023
 View chart
Advisor Group Holdings 142.00 $321.999200 468% Mar 2024
 View chart
Old Point Trust & Financial Services N A 125.00 $284.000000 100% Mar 2024
 View chart
Ancora Advisors 65.00 $147.998500 0% Mar 2024
 View chart
National Bank Of Canada /fi/ 50.00 $142.000000 0% Dec 2023
 View chart
Signature Resources Capital Management 14.00 $41.000400 0% Mar 2024
 View chart
Nelson, Van Denburg & Campbell Wealth Management 5.00 $11.000000 100% Mar 2024
 View chart
CWM 4.00 $0 100% Mar 2024
 View chart

Who sold out of Carisma Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2023 517k $2.2M
Wellington Management Company Sep 2023 66k $279k
Dimensional Fund Advisors Dec 2023 28k $82k
American Century Companies Sep 2023 16k $67k
SG Americas Securities Dec 2023 15k $43k
MetLife Investment Advisors Sep 2023 14k $60k
Ing Investment Management Sep 2023 11k $46k
Goldman Sachs Group Dec 2023 11k $31k
Wolverine Trading Dec 2023 10k $30k
Metropolitan Life Insurance Company Sep 2023 1.5k $6.2k
Cutler Dec 2023 705.00 $0
ORG Partners Dec 2023 200.00 $586.000000
Deuterium Capital Management Dec 2023 30.00 $155.001000
Northwestern Mutual Wealth Management Company Sep 2023 25.00 $106.000000